Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India. Manufactured for BluePoint Laboratories. NDC 68001-0313-56
Published August 24, 2022 · Recall initiated: July 27, 2022
Summary
FDA records drug Class III recall D-1349-2022, published August 24, 2022 and initiated July 27, 2022. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 4,160 vials; Lot: Lot #: FE22001A, Exp. Date 01/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Amerisource Health Services LLC
- Distributor
- Nationwide within the USA
- Lot
- Lot #: FE22001A, Exp. Date 01/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrimidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by:May 27, 2026
- FDAPrimidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by:May 27, 2026
- FDAMeclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mgApril 1, 2026
- FDAOxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, TheFebruary 18, 2026
- FDAAcetaminophen Injection, 10 mg/mL, 1,000 mg/100 mL, 100 mL VIAFLO container bag, Single Dose Container, ForAugust 24, 2022
- FDAFulvestrant Injection 250mg/5mL (50 mg/mL), Contains 2 Single-Dose Prefilled Syringes, Rx Only, Product ofAugust 24, 2022
Questions about this recall
Was Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India. Manufactured for BluePoint Laboratories. NDC 68001-0313-56 recalled?
Yes. FDA published recall D-1349-2022 on August 24, 2022. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter